Lorem ipsum dolor sit amet:

24h / 365days

We offer support for our customers

Mon - Fri 8:00am - 5:00pm (GMT +1)

Get in touch

Cybersteel Inc.
376-293 City Road, Suite 600
San Francisco, CA 94102

Have any questions?
+44 1234 567 890

Drop us a line

About us

Lorem ipsum dolor sit amet, consectetuer adipiscing elit.

Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quam felis, ultricies nec.


Non-alcoholic fatty liver disease (NAFLD) - a new challenge for the healthcare system

Non-alcoholic fatty liver disease is primarily based on too little exercise combined with too much energy intake. Thus, it can be referred to as a lifestyle-related disease. It is estimated that every third person in Germany has fatty liver, which develops into fatty liver inflammation (NASH) in up to 5% of those affected. Progressive fatty liver inflammation can have far-reaching health complications such as cirrhosis or liver cancer. Medication has not been approved to date. The most important intervention for those affected is a permanent change in their lifestyle.

In addition, half of NAFLD patients have other diseases and disorders of the metabolism such as dyslipidaemia (50%) and type 2 diabetes mellitus (60%). In addition, patients are often affected by obesity (72%, BMI>30kg/m2) and hypertension (78%) (see Alsenbesy M et al. Z Gastroenterol 2019; 57: 1209-1217).

Examples of our project work


The innovation project funded by the GBA offers the first opportunity to develop lifestyle interventions to meet the needs of NASH patients.

Learn more

NASH milieu study

How can you build a motivating, target group-specific communication that works sustainably with NASH patients?

Learn more

Patient guideline EASL

Based on the clinical guideline of the EASL on NAFLD/NASH, a patient guideline was developed that explains fatty liver and its causes, consequences and (non) medical treatment options in a simple and patient-understandable way.

Learn more
Copyright 2024 Kautzāµ. All Rights Reserved.
You are using an outdated browser. The website may not be displayed correctly. Close